# Merck Healthcare KGaA, Darmstadt trials: 56

ClinicalTrials.gov lists 56 trials with Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany as lead sponsor, 5 of them recruiting or not yet recruiting.

## The full list

Clinical trials led by Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany: 56 rows for $5, every trial on ClinicalTrials.gov. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/company/merck-healthcare-kgaa-darmstadt-germany-an-affiliate-of-merck-kgaa-dar

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 56
- Recruiting or not yet: 5
- Read on: November 19, 2026

## Trials

The 25 newest of 56, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 12, 2026 | NCT07932795 | Study of Multiple Ascending Doses (MAD) of M5542 in Participants With Moderate and Severe Eczema | Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany | Phase 1 | Not yet recruiting | Eczema | 56 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07932795) |
| September 25, 2026 | NCT07840612 | A Study to Assess the Effects of Probenecid on the Pharmacokinetics of Mirdametinib and Its Metabolites in Healthy Participants | Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany | Phase 1 | Recruiting | Healthy | 17 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07840612) |
| March 30, 2026 | NCT07499362 | Study of Pimicotinib in Japanese Participants With Tenosynovial Giant Cell Tumor (TGCT) (J-MANEUVER) | Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany | Phase 2 | Recruiting | Tenosynovial Giant Cell Tumor | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07499362) |
| January 14, 2026 | NCT07340827 | A Study to Compare the Efficacy and Safety of Follitropin Alfa/Lutropin Alfa Versus hMG in Japanese Participants With LH and FSH Deficiency... | Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany | Phase 3 | Recruiting | Infertility | 266 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07340827) |
| December 8, 2025 | NCT07269327 | An Ethno-bridging Study of Pergoveris in Healthy Premenopausal Participants of Japanese or Caucasian Origin | Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany | Phase 1 | Completed | Fertility | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07269327) |
| October 14, 2025 | NCT07215806 | Effect of Evobrutinib on Pharmacokinetics of a Combined Oral Contraceptive | Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany | Phase 1 | Completed | Healthy | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07215806) |
| October 9, 2025 | NCT07214935 | A TQT Study of Effect of M2951 on Cardiac Repolarization | Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany | Phase 1 | Completed | Healthy | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07214935) |
| October 9, 2025 | NCT07214922 | Relative Bioavailability of Evobrutinib Tablet Batches | Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany | Phase 1 | Completed | Healthy | 28 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07214922) |
| February 3, 2025 | NCT06806046 | Anti-CEACAM5 ADC Precemtabart Tocentecan (M9140) in Chinese Participants With Solid Tumors | Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany | Phase 1 | Completed | Solid Tumors, Colorectal Cancer | 12 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06806046) |
| September 19, 2024 | NCT06589726 | A TQT Study to Investigate the Effect of Enpatoran on Cardiac Repolarization in Healthy Participants | Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany | Phase 1 | Completed | Healthy | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06589726) |
| September 19, 2024 | NCT06589713 | Effect of Renal Impairment on Enpatoran Pharmacokinetics | Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany | Phase 1 | Completed | Renal Impairment | 34 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06589713) |
| August 29, 2024 | NCT06577337 | Phase 1 Single Ascending Doses (SAD) of M5542 in Healthy Participants | Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany | Phase 1 | Suspended | Healthy | 49 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06577337) |
| June 18, 2024 | NCT06463587 | Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis... | Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany | Phase 3 | Recruiting | Generalized Myasthenia Gravis | 264 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06463587) |
| May 14, 2024 | NCT06412848 | JAVEMACS: Japan AVElumab Maintenance And Continuous Treatment Study | Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany | Observational | Completed | Urothelial Carcinoma | 360 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06412848) |
| March 13, 2024 | NCT06308263 | Tuvusertib (M1774) Human Mass Balance and Absolute Bioavailability Study (DDRIVER Solid Tumors 303) | Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany | Phase 1 | Completed | Solid Tumor | 12 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06308263) |
| August 3, 2023 | NCT05974267 | Efficacy, Safety, and PK of M5717 in Combination With Pyronaridine as Chemoprevention in Adults and Adolescents With Asymptomatic... | Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany | Phase 2 | Completed | Malaria Infection | 192 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05974267) |
| July 5, 2023 | NCT05930808 | Concor® Bioequivalence Study in Chinese Participants (Darmstadt-Nantong) | Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany | Phase 1 | Completed | Healthy | 46 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05930808) |
| April 4, 2023 | NCT05797740 | Cladribine Tablets Level of Response Predictors in Clinical Practice (CLODINA) | Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany | Observational | Active not recruiting | Multiple Sclerosis | 366 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05797740) |
| January 18, 2023 | NCT05689047 | Phase IIa Proof of Concept Study of M5717-Pyronaridine in Adults and Adolescents With Acute Uncomplicated Plasmodium Falciparum Malaria... | Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany | Phase 2 | Completed | Acute Malaria | 38 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05689047) |
| December 19, 2022 | NCT05655832 | A Study to Investigate the Association of Real-world Sensor-derived Biometric Data With Clinical Parameters and Patient-reported Outcomes... | Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany | Not applicable | Completed | Pulmonary Disease, Chronic Obstructive | 77 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05655832) |
| December 14, 2022 | NCT05650164 | Treatment Outcomes in Japanese RCC Patients Treated With Avelumab Plus Axitinib as First-line Therapy: Retrospective Study (J-DART2) | Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany | Observational | Completed | Renal Cell Carcinoma | 171 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05650164) |
| September 14, 2022 | NCT05540327 | The Willow LTE Study With M5049 in Participants With SCLE, DLE and/or SLE (WILLOW LTE) | Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany | Phase 2 | Active not recruiting | Systemic Lupus Erythematosus | 381 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05540327) |
| August 29, 2022 | NCT05519540 | PK Study of Xevinapant (Debio 1143) in Healthy East Asian Participants | Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany | Phase 1 | Completed | Healthy | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05519540) |
| July 18, 2022 | NCT05463094 | GXR RM China BE Study (Darmstadt - Jiangsu) | Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany | Phase 1 | Completed | Healthy | 84 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05463094) |
| June 24, 2022 | NCT05431777 | A Study to Learn About the Study Medicine (Avelumab) in Japanese Patients With Urothelial Carcinoma That Has Spread | Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany | Observational | Completed | Urothelial Carcinoma | 79 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05431777) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1 | 37 |
| Phase 2 | 4 |
| Phase 3 | 4 |
| Phase 4 | 2 |
| Not applicable | 1 |
| Observational | 8 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 46 |
| Recruiting | 4 |
| Terminated | 2 |
| Active not recruiting | 2 |
| Suspended | 1 |
| Not yet recruiting | 1 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Multiple Sclerosis | 5 |
| Infertility | 3 |
| Malaria, Falciparum | 3 |
| Autoimmune Diseases | 2 |
| Carcinoma, Renal Cell | 2 |
| Malaria | 2 |
| Carcinoma, Transitional Cell | 2 |
| Hereditary Sensory and Autonomic Neuropathies | 2 |
| Lupus Erythematosus, Systemic | 2 |
| Lupus Erythematosus, Cutaneous | 2 |
| Diabetes Mellitus | 1 |
| Colorectal Neoplasms | 1 |
| Pulmonary Disease, Chronic Obstructive | 1 |
| Multiple Sclerosis, Relapsing-Remitting | 1 |
| Fatigue | 1 |
| Asymptomatic Infections | 1 |
| Acute malaria | 1 |
| Myasthenia Gravis | 1 |
| Giant Cell Tumor of Tendon Sheath | 1 |
| Lupus Erythematosus, Discoid | 1 |
| Eczema | 1 |
| Renal Insufficiency | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Ice suppliers in the United States](https://specstream.ai/data/businesses/ice-suppliers/united-states)
- [Civil engineering firms in the United States](https://specstream.ai/data/businesses/civil-engineering-firms/united-states)
- [Trucking companies in the United States](https://specstream.ai/data/businesses/trucking-companies/united-states)
- [Oncology practices in the United States](https://specstream.ai/data/businesses/oncology-practices/united-states)
- [Fertilizer stores in the United States](https://specstream.ai/data/businesses/fertilizer-stores/united-states)
- [B2B radio and television commercials companies in the United States](https://specstream.ai/data/businesses/b2b-radio-and-television-commercials-companies/united-states)
